Omid Zamani

1. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
   2011/09/01 by Richard Furie, Michelle Petri, Omid Zamani +18 · 31 citations
   Medicine · #Systemic Lupus Erythematosus Research #Multiple Sclerosis Research Studies #Liver Diseases and Immunity